Tech Company Financing Transactions
Traxxsson Funding Round
Traxxsson closed a $735 thousand funding round on 9/30/2014. Backers included private investors.
Transaction Overview
Company Name
Announced On
9/30/2014
Transaction Type
Venture Equity
Amount
$735,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4633 World Parkway Cir.
Saint Louis, MO 63134
USA
Saint Louis, MO 63134
USA
Phone
Undisclosed
Website
Email Address
Overview
Traxxsson is developing proprietary molecular tests to track diseases after diagnosis. These assays are targeted to allow clinicians to tailor therapeutics for each patient, and monitor treatment for success.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Puskas
Browse more venture capital transactions:
Prev: 9/30/2014: Pear Therapeutics venture capital transaction
Next: 9/30/2014: Vizzuality venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs